Gary Patou, Director at Xenon Pharmaceuticals Inc. (XENE), sold 15,196 shares at $41.05 ($624K) on 2023-12-14, disclosed to the SEC on 2023-12-15.
Open-market sale of $624k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.05 | 7,598 | $312K | 50.0% |
| 2 | $41.05 | 7,598 | $312K | 50.0% |
| Total | $41.05 avg | 15,196 | $624K | 100% |
| Filing → |
| XENE | SELL | 2023-12-15 | $1.0M | — | Filing → |
| XENE | SELL | 2022-11-28 | $276K | — | Filing → |
| XENE | BUY | 2017-08-14 | $21K | — | Filing → |